ArticleClinical case reports2023

Linear IgA bullous dermatosis and elevated bullous interleukin-6 levels: Responsive to treatment with Anti-IL-6 receptor monoclonals.

Stanley C Jordan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.